Ranbaxy may be under pressure as the US government has sued Ranbaxy for concealing and forging crucial data to get a favourable judgment in an ongoing investigation.
Ranbaxy : Bad new for stock, Sell above 534.90 for tgt 507.90 and below.
Monday, July 14, 2008
Ranbaxy : Bad new for stock, Sell above 534.90 for tgt 507.90 and below.
JOIN US!!
Send SMS for "STUDY" on 09825677777